News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,711 Results
Type
Article (983)
Press Release (23728)
Section
Business (12015)
Career Advice (122)
Deals (1508)
Drug Delivery (1)
Drug Development (2036)
Employer Resources (1)
FDA (481)
Job Trends (545)
News (15373)
Policy (735)
Tag
Academia (32)
Allergies (4)
Alliances (958)
ALS (6)
Alzheimer's disease (40)
Antibody-drug conjugate (ADC) (12)
Approvals (499)
Artificial intelligence (8)
Autoimmune disease (6)
Automation (1)
Bankruptcy (5)
Best Places to Work (452)
Biosimilars (1)
Bladder cancer (1)
Breast cancer (15)
Cancer (127)
Cardiovascular disease (17)
Career advice (99)
CAR-T (4)
Cell therapy (17)
Cervical cancer (1)
Clinical research (1927)
Collaboration (16)
Compensation (26)
COVID-19 (45)
CRISPR (2)
C-suite (7)
Cystic fibrosis (4)
Data (277)
Depression (4)
Dermatology (4)
Diabetes (12)
Diagnostics (249)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (3)
Drug pricing (7)
Duchenne muscular dystrophy (19)
Earnings (11681)
Editorial (3)
Employer resources (1)
Events (2170)
Executive appointments (2)
FDA (688)
Frontotemporal dementia (2)
Funding (16)
Gene editing (4)
Gene therapy (18)
GLP-1 (37)
Government (49)
Guidances (144)
Healthcare (650)
Immunology and inflammation (7)
Indications (6)
Infectious disease (49)
Inflammatory bowel disease (10)
Inflation Reduction Act (1)
Intellectual property (1)
Interviews (19)
IPO (1153)
IRA (2)
Job creations (124)
Job search strategy (94)
JPM (1)
Kidney cancer (1)
Labor market (1)
Layoffs (11)
Leadership (3)
Legal (192)
Liver cancer (1)
Lung cancer (30)
Lymphoma (18)
Machine learning (1)
Manufacturing (12)
MASH (10)
Medical device (662)
Medtech (667)
Mergers & acquisitions (379)
Metabolic disorders (42)
mRNA (1)
Multiple sclerosis (6)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (6)
Neuroscience (83)
NextGen: Class of 2026 (154)
Non-profit (80)
Obesity (14)
Opinion (7)
Ovarian cancer (6)
Pain (3)
Pancreatic cancer (4)
Parkinson's disease (7)
Patents (4)
Patient recruitment (3)
Peanut (1)
People (700)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (422)
Phase 2 (768)
Phase 3 (817)
Pipeline (723)
Policy (7)
Postmarket research (108)
Preclinical (139)
Prostate cancer (6)
Radiopharmaceuticals (14)
Rare diseases (19)
Real estate (115)
Recruiting (1)
Regulatory (594)
Reports (2)
Research institute (28)
Resumes & cover letters (14)
RSV (1)
Schizophrenia (7)
Series A (3)
Sickle cell disease (2)
Special edition (1)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (46)
Supply chain (2)
Tariffs (1)
Vaccines (14)
Venture capital (1)
Weight loss (12)
Women's health (3)
Worklife (1)
Date
Last 7 days (29)
Last 30 days (116)
Last 365 days (1388)
2026 (346)
2025 (1404)
2024 (1561)
2023 (1728)
2022 (1952)
2021 (2013)
2020 (1798)
2019 (1311)
2018 (1057)
2017 (739)
2016 (454)
2015 (703)
2014 (451)
2013 (240)
2012 (1989)
2011 (3515)
2010 (464)
Location
Africa (31)
Alabama (5)
Arizona (9)
Asia (1552)
Australia (169)
California (536)
Canada (123)
China (45)
Colorado (38)
Connecticut (31)
Delaware (14)
Europe (3373)
Florida (71)
Georgia (17)
Illinois (49)
India (1)
Indiana (49)
Iowa (2)
Japan (15)
Kansas (2)
Kentucky (12)
Louisiana (9)
Maine (14)
Maryland (66)
Massachusetts (356)
Michigan (16)
Minnesota (39)
Missouri (8)
Montana (3)
Nebraska (2)
Nevada (6)
New Hampshire (1)
New Jersey (168)
New York (131)
North Carolina (81)
Northern California (295)
Ohio (13)
Oregon (1)
Pennsylvania (143)
Rhode Island (1)
South America (56)
Southern California (214)
Tennessee (9)
Texas (60)
United States (2002)
Utah (28)
Virginia (7)
Washington D.C. (2)
Washington State (71)
Wisconsin (14)
24,711 Results for "133".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
MAIA Biotechnology Announces $1.33 Million Private Placement
MAIA Biotechnology, Inc. announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 578,643 shares of common stock at a purchase price of $2.295 per share, in a private placement to accredited investors.
March 26, 2024
·
4 min read
Press Releases
NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially
October 10, 2024
·
4 min read
Leukapheresis Market ($133.90Mn by 2028) Growth Forecast at 8.7% CAGR During 2021 to 2028 | The Insight Partners
According to our new research study on “Leukapheresis Market to 2028 – Global Analysis and Forecast – by Product Type, Application, End User, and Geography,” the Leukapheresis Market is projected to reach 133.90 million in 2028 from US$ 74.48 million in 2021
May 31, 2023
·
7 min read
Drug Development
AMGEN PRESENTS NEW AMG 133 PHASE 1 CLINICAL DATA AT WCIRDC 2022
Amgen (NASDAQ:AMGN) today announced new Phase 1 data from AMG 133, a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule.
December 1, 2022
·
13 min read
Press Releases
Novo Nordisk’s sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024
August 7, 2024
·
3 min read
Clinical Trial Supplies Market Size to Surpass US$ 13.3 Bn by 2030
According to Report, the Clinical Trial Supplies market size is estimated to surpass around US$ 13.3 billion by 2030 and is expected to registered growth at a CAGR of 17.3% from 2021 to 2030.
May 19, 2022
·
5 min read
Breast Imaging Technologies Market Size to Reach $8,133.80 Million by 2030
According to QY Research Medical, the breast imaging technologies market size was valued at $3,737.83 million in 2020, and is projected to reach $8,133.80 million by 2030, growing at a CAGR of 8.1% from 2021 to 2030.
June 2, 2022
·
7 min read
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
Scinai Immunotherapeutics Ltd. announced that it has entered into a definitive agreement for the purchase and sale of 1,146,552 of the Company’s American Depositary Shares, each ADS representing four hundred ordinary shares, at a purchase price of yesterday’s closing price of $1.16 per ADS, in a registered direct offering.
September 15, 2023
·
6 min read
Non-Invasive Aesthetic Treatment Market to Hit US$ 133.87 Bn by 2029
The global non-invasive aesthetic treatment market size is anticipated to hit US$ 133.87 billion by 2029 with a registered CAGR of 12.4% from 2021 to 2030.
March 30, 2022
·
5 min read
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
Scinai Immunotherapeutics Ltd. announced the closing of its previously announced registered direct offering of 1,146,552 of the Company’s American Depositary Shares, each ADS representing four hundred ordinary shares, at a purchase price of $1.16 per ADS.
September 19, 2023
·
5 min read
1 of 2,472
Next
